| |
| |
|
| Insider
Information: |
Trizzino John |
| Relationship: |
President and COO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,056 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,972 |
|
|
| Total
Value |
$10,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President and COO |
2024-03-10 |
27,972 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4 |
D |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4/A |
AS |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, CBO and CFO |
• – – |
2019-09-08 |
4 |
D |
$5.50 |
$9,422 |
D/D |
(1,713) |
10,378 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-08-19 |
4 |
D |
$36.22 |
$11,482 |
D/D |
(317) |
4,266 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and COO |
• – – |
2024-03-10 |
4 |
D |
$5.45 |
$12,132 |
D/D |
(2,226) |
27,972 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-12-14 |
4 |
D |
$17.23 |
$13,319 |
D/D |
(773) |
6,922 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-06-25 |
4 |
D |
$51.67 |
$14,364 |
D/D |
(278) |
3,928 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2023-03-10 |
4 |
D |
$6.52 |
$16,111 |
D/D |
(2,471) |
9,060 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2015-07-31 |
4 |
B |
$3.63 |
$18,506 |
D/D |
5,098 |
33,709 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2016-01-31 |
4 |
B |
$3.63 |
$21,254 |
D/D |
5,855 |
39,564 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
Snr. VP, Int & Govt Alliances |
• – – |
2011-08-09 |
4 |
B |
$1.18 |
$23,800 |
D/D |
20,000 |
10,000 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2015-01-31 |
4 |
B |
$3.63 |
$23,998 |
D/D |
6,611 |
28,611 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2014-06-17 |
4 |
B |
$4.51 |
$24,800 |
D/D |
5,500 |
22,000 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2014-06-16 |
4 |
B |
$4.59 |
$25,240 |
D/D |
5,500 |
16,500 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
D |
$111.18 |
$27,461 |
D/D |
(247) |
52,761 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2023-03-10 |
4 |
OE |
$6.52 |
$30,051 |
D/D |
4,609 |
11,531 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
D |
$171.74 |
$30,913 |
D/D |
(180) |
477 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
D |
$174.84 |
$31,296 |
D/D |
(179) |
477 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
D |
$177.29 |
$31,735 |
D/D |
(179) |
478 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, CBO and CFO |
• – – |
2019-09-11 |
4 |
S |
$5.72 |
$31,911 |
D/D |
(5,578) |
4,800 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-09 |
4 |
AS |
$168.09 |
$31,937 |
D/D |
(190) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-09-26 |
4 |
D |
$18.87 |
$32,249 |
D/D |
(1,709) |
6,095 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-07 |
4 |
AS |
$176.60 |
$33,559 |
D/D |
(190) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-07 |
4 |
AS |
$178.03 |
$34,004 |
D/D |
(191) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2014-06-13 |
4 |
B |
$4.47 |
$49,214 |
D/D |
11,000 |
11,000 |
2.74 |
- |
|
91 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
